COVID Treatment Controversy

A recent discussion highlights the controversial use of Ivamectin in COVID treatment, referencing various clinical trials from around the world. Notably, a study involving frontline workers showed that those receiving Ivamectin had zero COVID infections compared to nearly 50% in the control group. Despite the promising results, skepticism remains due to the lack of gold standard trials, raising questions about the broader implications of these findings.